The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of the JAK2 V617F mutational status in coronary patients.
K. Gasser
No relevant relationships to disclose
A. Muendlein
No relevant relationships to disclose
N. Stark
No relevant relationships to disclose
T. Winder
No relevant relationships to disclose
P. Rein
No relevant relationships to disclose
C. H. Saely
No relevant relationships to disclose
K. Geiger
No relevant relationships to disclose
S. Geller-Rhomberg
No relevant relationships to disclose
B. L. Hartmann
No relevant relationships to disclose
B. Kohler
No relevant relationships to disclose
H. Drexel
No relevant relationships to disclose
A. Lang
No relevant relationships to disclose